| Literature DB >> 21845108 |
Grzegorz Chladek1, Anna Mertas, Izabela Barszczewska-Rybarek, Teresa Nalewajek, Jarosław Zmudzki, Wojciech Król, Jan Lukaszczyk.
Abstract
Soft liner materials in oral cavity environments are easily colonized both by fungi and dental plaque. These factors are the cause of mucosal infections. The microorganism that most frequently colonizes soft liner materials is Candida albicans. Colonization occurs on the surface of materials and within materials. A solution to this problem might involve modification of soft liner materials with silver nanoparticles (AgNPs). In this article, we present results showing the antifungal efficacy of silicone soft lining materials modified with AgNPs. The modification process was conducted by dissolving both material components (base and catalyst) in a colloidal solution of AgNPs and evaporating the solvent. Composites with various AgNP concentrations (10, 20, 40, 80, 120 and 200 ppm) were examined. The in vitro antifungal efficacy (AFE) of composite samples was 16.3% to 52.5%.Entities:
Keywords: Candida albicans; antifungal; dental materials; nanotechnology in dentistry; silver nanoparticles; soft liner
Mesh:
Substances:
Year: 2011 PMID: 21845108 PMCID: PMC3155381 DOI: 10.3390/ijms12074735
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Silver nanoparticle (AgNP) size distribution in 30 ppm solution.
Figure 2Polymerized material samples: Ufi Gel SC (UG) and composites with different AgNP concentrations.
Figure 3Micrographs showing AgNPs in a composite with 160 ppm AgNPs. Scanning transmission electron image using (a) the wet-STEM detector and (b) the gaseous secondary electron detector (GSED).
The average antifungal effect for UG and UG/AgNP composites against Candida albicans. CFU, colony forming units; AFE, antifungal efficacy; Vt, the number of viable fungal colonies of the test specimen; SD, standard deviation.
| AgNPs ppm | CFU/mL (Vt) ×103 | SD ×103 | AFE | SD |
|---|---|---|---|---|
| 1.43 | 0.22 | 0% | - | |
| 0.96 | 0.16 | 16.3% | 6.2% | |
| 0.87 | 0.04 | 24.2% | 3.5% | |
| 0.79 | 0.04 | 31.5% | 3.1% | |
| 0.74 | 0.06 | 36.6% | 5.4% | |
| 0.60 | 0.07 | 47.8% | 6.3% | |
| 0.55 | 0.07 | 52.2% | 6.2% | |
| - | - | - |
Figure 4Example results of antifungal tests against Candida albicans after 17 h of incubation with UG and UG SC/AgNP composites.